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Introduction: Mesenchymal stromal cell (MSC) infusion could be a mean to
establish donor-specific immunological tolerance in solid organ recipients. The
aim of this phase 2 study was test the hypothesis of possible induction of
operative tolerance by third-party MSC in liver transplant (LT) recipients.
Methods: 10 stable and low-risk LT recipients under standard immunosup-
pression (Tac-MMF- low dose steroids) received 1.5–3 9 106/kg third-party
MSCs on post-operative day 3 ! 2. By protocol, progressive weaning of
immunosuppression was attempted in patients who did not develop rejection
and had normal graft function and month-6 graft biopsy. Tacrolimus was
progressively tapered from day 180 to be discontinued by day 270. After day-
270 graft biopsy, MMF was progressively tapered and definitely discontinued
by day 365 in the absence of rejection.
Results: One patient from the MSC group was excluded from immunosup-
pression withdrawal attempt due to HCC recurrence, and the 9 others met the
necessary criteria. In one patient, tacrolimus and MMF withdrawal was
performed without rejection. In two patients, MMF monotherapy was achieved
at month 9, but graft rejection occurred during MMF withdrawal and was
successfully treated by tacrolimus reintroduction. In 6 patients, the transam-
inases significantly increased during tacrolimus withdrawal. In these cases,
withdrawal was cancelled and liver tests normalised after increase of the
tacrolimus dose. No graft was lost due to the withdrawal attempt.
Conclusion: A single post transplant MSC injection is not sufficient to induce
operative tolerance after LT.
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Introduction: Transplantation of kidneys from expanded criteria donors
(ECD) has increased in the past years because of the shortage of grafts.
Two methods of preservation are available, static cold storage method (PS) or
hypothermic machine perfusion (MP). The aim of our study was to compare
outcomes of the transplantation depending on the mode of graft preservation.
Methodology: Our study includes all kidney transplantations performed from
ECD between 2010 and 2014 in Amiens, Lille and Rouen. Patients were
followed until 01/01/2016. We analyzed graft and patient survival, slow
recovery (SGF) and delayed renal function (DGF) and changes in glomerular
filtration rate (GFR).
Results: Two hundred and ninety-two grafts were on CS and 150 were
connected to MP. The use of an MP was independently associated with a
decreased risk of occurrence of SGF (OR = 0.28 (0.15–0.53), p < 0.01) or
DGF (OR = 0.39 (from 0.24 to 0.65), p < 0.01). GFR was higher at the end of
hospitalization for transplantation and at 1 and 3 months after transplantation
(37.0 ! 20.0, 42.4 ! 20.9 and 45.3 ! 22.1 mL/min/1.73 m2 vs 29.9 ! 17.8,
35.9 ! 20 and 40.9 ! 20.4 mL/min/1.73 m2 (p < 0.05) in the MP group.
Hospitalization duration was reduced by an average of 4 days in transplant
patients fromMP (p < 0.01). We observed an increase in the rate of graft artery
stenosis in the PS group (10.3 vs 1.3%, p < 0.01) and a non-significant trend to
an improved graft survival at 1 year in the MP group (86.7 % vs 83.2 %,
p = NS).
Conclusion: The use of perfusion machines for kidneys grafts from ECD can
limit the consequences of ischemia-reperfusion. This may explain the decrease
risk in delayed recovery of graft function and the shorter duration of initial
hospitalization. It could also have a beneficial effect on the risk of transplant
renal artery stenosis.
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Ischemia-reperfusion induced by kidney transplantation leads to the develop-
ment of tubular injury and interstitial inflammation that need to be controlled to
avoid fibrosis development. We hypothesized that microRNAs are involved in
the regulation of the balance between lesions and adaptive repair. Using HK2
human proximal tubular epithelial cells, we studied the response to pro-
inflammatory cytokines and the regulation of miR-146a. We explored its
targets after stimulation by IL-1b. In vivo we explored the effect of unilateral
renal ischemia-reperfusion injury (IRI) in wild-type (WT) or miR-146a invali-
dated mice.
In pro-inflammatory conditions, we identified miR-146a to be transcription-
ally upregulated by ligands of the interleukin-1-toll-like receptor signaling in
HK2 cells. IL-1b treatment induced miR-146a expression through the activa-
tion of NF-jB. MiR-146a acted as a negative feedback regulator of this critical
pathway by targeting IRAK1, thus decreasing CXCL8/CXCL1 expression by
injured tubular cells. In vivo in mice, miR-146a was found to be induced in
response to renal IRI 7 days after the injury. In human, miR-146a was found to
be induced in the renal allograft of patients who experienced acute tubular
necrosis early after transplantation as compared to patients with normal
allograft biopsy results (p < 0.05). Mir-146a levels were also increased in urine
samples collected 10 days after renal transplantation in recipients of a
deceased donor kidney as compared to recipients of a living donor kidney
(p < 0.01). Fourteen days after unilateral IRI, miR-146a"/" mice had greater
tubular injury, inflammatory infiltrate and fibrosis compared with WT mice.
Inhibition of the CXCL8/CXCL1 signaling using reparixin, a CXCR2 inhibitor,
prevented the development of tubular injury, inflammation and fibrosis after IRI
inmiR-146a"/"mice. These results highlight miR-146a as a key mediator of the
renal response to injury by limiting the consequences of inflammation.
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The shortage of kidney grafts led to retrieve organs from old donors with one or
more co-morbidities, considered as “expanded criteria donors” (ECD). In
France, since 2012, the Agency of biomedicine (ABM) has recommended the
use of machines perfusion (MP) to preserve kidneys from this donor population
to improve kidney preservation and the transplantation outcomes, with the
creation of a specific lump sum financing the additional costs of this strategy.
This study evaluates the impact of MP vs cold storage (CS), for the period
2011–2014 with kidneys from ECD.
From the ABM database (Cristal), the effect of MP on the delayed graft
function (DGF) was analyzed using a multivariate logistic model excluding pre-
emptive transplants and primary non functions (PNF). In addition, transplants
from the same donor, whose one kidney preserved by MP and the other by CS
(population of twins), were analyzed using a mixed model. Co-morbidities of
recipients are more frequent and the age of donors and recipients is
significantly higher for kidney preserved by MP (n = 801) vs CS (n = 3515).
With 16% of DGF for MP vs 29% for CS, MP has a protective effect on the DGF
(OR adjusted = 0.45, CI [0.36, 0.56]). In the population of the twins (84 pairs,
168 grafts), we observed 7% of DGF for MP vs 33% for CS and an adjusted OR
0.19 (CI [0.06; 0.58]). The durations of hospitalization and dialysis after
transplantation are shorter with fewer sessions of dialysis.
Our results confirm the reduction in the incidence of the DGF of ECD
kidneys preserved by machines, with 2.2 times less risk despite a population
more at risk in this group, and a lower 5.2 times risk in the population of the
kidneys “twins”. It remains to assess the impact of the DGF in the long term
survival and measure the cost effectiveness of this strategy.
Abstracts of the 16th Annual Congress of the French Speaking Society of Transplantation Oral
ª 2017 The Authors
Transplant International ª2017 European Society for Organ Transplantation8 Vol. 30 (Suppl. 1), 5–25
